Vitamin D endocrine system involvement in autoimmune rheumatic diseases

Autoimmunity Reviews

Volumn 11, Issue 2, 2011, Pages 84-87

  Cutolo, Maurizio ^a   Pizzorni, Carmen ^a   Sulli, Alberto ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

D hormone; Innate and adaptive immunity; Rheumatoid arthritis; Systemic lupus erythematosus; Vitamin D

Indexed keywords

COLECALCIFEROL; IMMUNOGLOBULIN; VITAMIN D; VITAMIN D RECEPTOR; AROMATASE; AROMATASE INHIBITOR; CALCIDIOL 1 MONOOXYGENASE; CALCITRIOL RECEPTOR;

ADAPTIVE IMMUNITY; ANTIMICROBIAL ACTIVITY; AUTOIMMUNE DISEASE; B LYMPHOCYTE; BREAST CANCER; CELL GROWTH; CIRCANNUAL RHYTHM; DISEASE COURSE; ENDOCRINE SYSTEM; ENZYME ACTIVITY; ENZYME INHIBITION; HOMEOSTASIS; HUMAN; IMMUNOGLOBULIN PRODUCTION; IMMUNOMODULATION; INNATE IMMUNITY; MACROPHAGE; MONOCYTE; REVIEW; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS; SPRING; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE; TUBERCULOSIS; WINTER; BREAST TUMOR; CYTOLOGY; DRUG EFFECT; FEMALE; IMMUNOLOGY; METABOLISM; PATHOLOGY; SEASON; SKIN;

25-HYDROXYVITAMIN D3 1-ALPHA-HYDROXYLASE; ADAPTIVE IMMUNITY; AROMATASE; AROMATASE INHIBITORS; ARTHRITIS, RHEUMATOID; B-LYMPHOCYTES; BREAST NEOPLASMS; ENDOCRINE SYSTEM; FEMALE; HOMEOSTASIS; HUMANS; IMMUNITY, INNATE; LUPUS ERYTHEMATOSUS, SYSTEMIC; RECEPTORS, CALCITRIOL; SEASONS; SKIN; TUBERCULOSIS; VITAMIN D;

EID: 84858382164     PISSN: 15689972     EISSN: 18730183     Source Type: Journal    
DOI: 10.1016/j.autrev.2011.08.003     Document Type: Review

References (43)

1. Cutolo M., Straub R.H. Insights into endocrine-immunological disturbances in autoimmunity and their impact on treatment. Arthritis Res Ther 2009, 11:218.
2. Cutolo M., Plebani M., Shoenfeld Y., Adorini L., Tincani A. Vitamin D endocrine system and the immune response in rheumatic diseases. Vitam Horm 2011, 86:327-351.
3. Hewison M. Vitamin D and innate and adaptive immunity. Vitam Horm 2011, 86:24-62.
4. Pelajo C.F., Lopez-Benitez J.M., Miller L.C. Vitamin D and autoimmune rheumatologic disorders. Autoimmun Rev 2010, 9:507-510.
5. Selmi C., Tsuneyama K. Nutrition, geoepidemiology, and autoimmunity. Autoimmun Rev 2010, 9:A267-A270.
6. Cutolo M. Vitamin D or hormone D deficiency in autoimmune rheumatic diseases, including undifferentiated connective tissue disease. Arthritis Res Ther 2008, 10:123-127.
7. Arnson Y., Amital H., Agmon-Levin N., Alon D., Sánchez-Castañón M., López-Hoyos M., et al. Serum 25-OH vitamin D concentrations are linked with various clinical aspects in patients with systemic sclerosis: a retrospective cohort study and review of the literature. Autoimmun Rev 2011, 10:490-494.
8. Hajas A., Sandor J., Csathy L., Csipo I., Barath S., Paragh G., et al. Vitamin D insufficiency in a large MCTD population. Autoimmun Rev 2011, 10:317-324.
9. Zold E., Szodoray P., Nakken B., Barath S., Kappelmayer J., Csathy L., et al. Alfacalcidol treatment restores derailed immune-regulation in patients with undifferentiated connective tissue disease. Autoimmun Rev 2011, 10:155-162.
10. Smolders J., Peelen E., Thewissen M., Menheere P., Tervaert J.W., Hupperts R., et al. The relevance of vitamin D receptor gene polymorphisms for vitamin D research in multiple sclerosis. Autoimmun Rev 2009, 8:621-626.
11. Cantorna M.T. Mechanisms underlying the effect of vitamin D on the immune system. Proc Nutr Soc 2010, 69:286-289.
12. Krutzik S.R., Hewison M., Liu P.T., Robles J.A., Stenger S., Adams J.S., et al. IL-15 links TLR2/1-induced macrophage differentiation to the vitamin D-dependent antimicrobial pathway. J Immunol 2008, 181:7115.
13. Gauzzi M.C., Purificato C., Donato K., et al. Suppressive effect of 1alpha,25- dihydroxyvitamin D3 on type I IFN-mediated monocyte differentiation into dendritic cells: impairment of functional activities and chemotaxis. J Immunol 2005, 174:270-276.
14. Lagishetty V., Chun R.F., Liu N.Q., Lisse T.S., Adams J.S., Hewison M. 1alpha-hydroxylase and innate immune responses to 25-hydroxyvitamin D in colonic cell lines. J Steroid Biochem Mol Biol 2010, 121:228-233.
15. Campbell G.R., Spector S.A. Hormonally active vitamin D3 (1alpha,25-dihydroxycholecalciferol) triggers autophagy in human macrophages that inhibits HIV-1 infection. J Biol Chem 2011, 286:18890-18892.
16. White J.H. Vitamin D as an inducer of cathelicidin antimicrobial peptide expression: past, present and future. J Steroid Biochem Mol Biol 2010, 121:234-238.
17. Shapira Y., Agmon-Levin N., Shoenfeld Y. Mycobacterium tuberculosis, autoimmunity, and vitamin D. Clin Rev Allergy Immunol 2010, 38:169-177.
18. Cutolo M., Otsa K., Laas K., Yprus M., Lehtme R., Secchi M.E., et al. Circannual vitamin D serum levels and disease activity in rheumatoid arthritis: Northern versus Southern Europe. Clin Exp Rheumatol 2006, 24:702-704.
19. Mouterde G., Lukas C., Logeart I., Flipo R.M., Rincheval N., Daurès J.P., et al. Predictors of radiographic progression in the ESPOIR cohort: the season of first symptoms may influence the short-term outcome in early arthritis. Ann Rheum Dis 2011, 70:1251-1256.
20. Cutolo M. Circadian and circannual rhythms in RA. Nat Rev Rheumatol 2011, 7:500-502.
21. Cutolo M., Otsa K., Uprus M., Paolino S., Seriolo B. Vitamin D in rheumatoid arthritis. Autoimmun Rev 2007, 7:59-64.
22. Rossini M., Maddali Bongi S., La Montagna G., Minisola G., Malavolta N., Bernini L., et al. Vitamin D deficiency in rheumatoid arthritis: prevalence, determinants and associations with disease activity and disability. Arthritis Res Ther 2010, 12:R216.
23. Peelen E., Knippenberg S., Muris A.H., Thewissen M., Smolders J., Tervaert J.W., et al. Effects of vitamin D on the peripheral adaptive immune system: A review. Autoimmun Rev May 18 2011, [Electronic publication ahead of print] PMID: 21621002 [PubMed - as supplied by publisher].
24. D'Ambrosio D., Cippitelli M., Cocciolo M.G., Mazzeo D., Di Lucia P., Lang R., et al. Inhibition of IL-12 production by 1,25-dihydroxyvitamin D3. Involvement of NF-kappaB downregulation in transcriptional repression of the p40 gene. J Clin Invest 1998, 101:252-262.
25. Mora J.R., Iwata M., von Andrian U.H. Vitamin effects on the immune system:vitamins A and D take centre stage. Nat Rev 2008, 8:685-698.
26. Joshi S., Pantalena L.C., Liu X.K., Gaffen S.L., Liu H., Rohowsky-Kochan C., et al. 1,25-Dihydroxyvitamin D3 Ameliorates Th17 Autoimmunity via Transcriptional Modulation of Interleukin-17A. Mol Cell Biol 2011, 31(17):3653-3669.
27. Colin E.M., Asmawidjaja P.S., van Hamburg J.P., Mus A.M., van Driel M., Hazes J.M., et al. 1,25-dihydroxyvitamin D3 modulates Th17 polarization and interleukin-22 expression by memory T cells from patients with early rheumatoid arthritis. Arthritis Rheum 2010, 62:132-142.
28. Khoo A.L., Chai L.Y., Koenen H.J., Sweep F.C., Joosten I., Netea M.G., et al. Regulation of cytokine responses by seasonality of vitamin D status in healthy individuals. Clin Exp Immunol 2011, 164:72-79.
29. Chen S., Sims G.P., Chen X.X., Gu Y.Y., Chen S., Lipsky P.E. Modulatory effects of 1,25-dihydroxyvitamin D3 on human B cell differentiation. J Immunol 2007, 179:1634-1647.
30. Chen S., Sims G.P., Chen X.X., et al. Modulatory effects of 1,25-dihydroxyvitamin D3 on human B cell differentiation. J Immunol 2007, 179:1634-1638.
31. Geldmeyer-Hilt K., Heine G., Hartmann B., Baumgrass R., Radbruch A., Worm M. 1,25-dihydroxyvitamin D3 impairs NF-κB activation in human naïve B cells. Biochem Biophys Res Commun 2011, 407:699-702.
32. Cutolo M., Otsa K. Review: vitamin D, immunity and lupus. Lupus 2008, 17:6-10.
33. Cutolo M., Otsa K., Paolino S., Yprus M., Veldi T., Seriolo B. Vitamin D involvement in rheumatoid arthritis and systemic lupus erythaematosus. Ann Rheum Dis 2009, 68:446-447.
34. Amital H., Szekanecz Z., Szücs G., Dankó K., Nagy E., Csépány T., et al. Serum concentrations of 25-OH vitamin D in patients with systemic lupus erythematosus (SLE) are inversely related to disease activity: is it time to routinely supplement patients with SLE with vitamin D?. Ann Rheum Dis 2010, 69:1155-1157.
35. Ritterhouse L.L., Crowe S.R., Niewold T.B., Kamen D.L., Macwana S.R., Roberts V.C., et al. Vitamin D deficiency is associated with an increased autoimmune response in healthy individuals and in patients with systemic lupus erythematosus. Ann Rheum Dis 2011, 70:1569-1574.
36. Brodie A.M., Lu Q., Long B.J., Fulton A., Chen T., Macpherson N., et al. Aromatase and COX-2 expression in human breast cancers. J Steroid Biochem Mol Biol 2001, 79:41-47.
37. Krishnan A.V., Swami S., Peng L., Wang J., Moreno J., Feldman D. Tissue-selective regulation of aromatase expression by calcitriol: implications for breast cancer therapy. Endocrinology 2010, 151:32-42.
38. Wheler J., Johnson M., Seidman A. Adjuvant therapy with aromatase inhibitors for postmenopausal women with early breast cancer: evidence and ongoing controversy. Semin Oncol 2006, 33:672-680.
39. Cutolo M., Straub R.H., Bijlsma J.W. Neuroendocrine-immune interactions in synovitis. Nat Clin Pract Rheumatol 2007, 3:627-634.
40. Cutolo M, Soldano S, Villaggio B. Vitamin D modulates aromatase expression in human macrophages and downregulates proinflammatory production. submitted for publication.
41. Wang J., Nuite M., McAlindon T.E. Association of estrogen and aromatase gene polymorphisms with systemic lupus erythematosus. Lupus 2010, 19:734-744.
42. Cutolo M. Hormone therapy in rheumatic diseases. Curr Opin Rheumatol 2010, 22:257-263.
43. Souberbielle J.C., Body J.J., Lappe J.M., Plebani M., Shoenfeld Y., Wang T.J., et al. Vitamin D and musculoskeletal health, cardiovascular disease, autoimmunity and cancer: recommendations for clinical practice. Autoimmun Rev 2010, 9:709-715.